{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["NSAID", "complementary medicine", "cyclooxygenase inhibitor", "cyclosporine", "ginseng", "green tea", "herbal medical products", "inflammatory bowel disease", "methotrexate", "rheumatoid arthritis"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35329893", "DateRevised": {"Year": "2023", "Month": "09", "Day": "17"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "03", "Day": "12"}], "Language": ["eng"], "ELocationID": ["1567", "10.3390/jcm11061567"], "Journal": {"ISSN": "2077-0383", "JournalIssue": {"Volume": "11", "Issue": "6", "PubDate": {"Year": "2022", "Month": "Mar", "Day": "12"}}, "Title": "Journal of clinical medicine", "ISOAbbreviation": "J Clin Med"}, "ArticleTitle": "Herb-Drug Interaction in Inflammatory Diseases: Review of Phytomedicine and Herbal Supplements.", "Abstract": {"AbstractText": ["Many people worldwide use plant preparations for medicinal purposes. Even in industrialized regions, such as Europe, where conventional therapies are accessible for the majority of patients, there is a growing interest in and usage of phytomedicine. Plant preparations are not only used as alternative treatment, but also combined with conventional drugs. These combinations deserve careful contemplation, as the complex mixtures of bioactive substances in plants show a potential for interactions. Induction of CYP enzymes and pGP by St John's wort may be the most famous example, but there is much more to consider. In this review, we shed light on what is known about the interactions between botanicals and drugs, in order to make practitioners aware of potential drug-related problems. The main focus of the article is the treatment of inflammatory diseases, accompanied by plant preparations used in Europe. Several of the drugs we discuss here, as basal medication in chronic inflammatory diseases (e.g., methotrexate, janus kinase inhibitors), are also used as oral tumor therapeutics."]}, "AuthorList": [{"Identifier": ["0000-0002-5661-5376"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Clinical Pharmacology, Medical Faculty Carl Gustav Carus, Technische Universit\u00e4t Dresden, 01069 Dresden, Germany."}], "LastName": "Lippert", "ForeName": "Annemarie", "Initials": "A"}, {"Identifier": ["0000-0003-0845-6793"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Clinical Pharmacology, Medical Faculty Carl Gustav Carus, Technische Universit\u00e4t Dresden, 01069 Dresden, Germany."}], "LastName": "Renner", "ForeName": "Bertold", "Initials": "B"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "J Clin Med", "NlmUniqueID": "101606588", "ISSNLinking": "2077-0383"}, "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Sammons H.M., Gubarev M.I., Krepkova L.V., Bortnikova V.V., Corrick F., Job K.M., Sherwin C.M., Enioutina E.Y. Herbal medicines: Challenges in the modern world. Part 2. European Union and Russia. Expert Rev. Clin. Pharmacol. 2016;9:1117\u20131127. doi: 10.1080/17512433.2016.1189326.", "ArticleIdList": ["10.1080/17512433.2016.1189326", "27171366"]}, {"Citation": "Madsen H., Andersen S., Nielsen R.G., Dolmer B.S., H\u00f8st A., Damkier A. Use of complementary/alternative medicine among paediatric patients. Eur. J. Pediatr. 2003;162:334\u2013341. doi: 10.1007/s00431-003-1180-4.", "ArticleIdList": ["10.1007/s00431-003-1180-4", "12692715"]}, {"Citation": "Bush T.M., Rayburn K.S., Holloway S.W., Sanchez-Yamamoto D.S., Allen B.L., Lam T., So B.K., de Tran H., Greyber E.R., Kantor S., et al. Adverse interactions between herbal and dietary substances and prescription medications: A clinical survey. Altern. Ther. Health Med. 2007;13:30\u201335.", "ArticleIdList": ["17405676"]}, {"Citation": "Lakatos P.L., Czegledi Z., David G., Kispal Z., Kiss L.S., Palatka K., Kristof T., Nagy F., Salamon A., Demeter P., et al. Association of adherence to therapy and complementary and alternative medicine use with demographic factors and disease phenotype in patients with inflammatory bowel disease. J. Crohn\u2019s Colitis. 2010;4:283\u2013290. doi: 10.1016/j.crohns.2009.11.011.", "ArticleIdList": ["10.1016/j.crohns.2009.11.011", "21122517"]}, {"Citation": "Djuv A., Nilsen O.G., Steinsbekk A. The co-use of conventional drugs and herbs among patients in Norwegian general practice: A cross-sectional study. BMC Complement. Altern. Med. 2013;13:295. doi: 10.1186/1472-6882-13-295.", "ArticleIdList": ["10.1186/1472-6882-13-295", "PMC4228482", "24171723"]}, {"Citation": "Agbabiaka T.B., Spencer N.H., Khanom S., Goodman C. Prevalence of drug-herb and drug-supplement interactions in older adults: A cross-sectional survey. Br. J. Gen. Pract. 2018;68:e711\u2013e717. doi: 10.3399/bjgp18X699101.", "ArticleIdList": ["10.3399/bjgp18X699101", "PMC6145997", "30249608"]}, {"Citation": "Garcia-Alvarez A., Egan B., de Klein S., Dima L., Maggi F.M., Isoniemi M., Ribas-Barba L., Raats M.M., Meissner E.M., Badea M., et al. Usage of plant food supplements across six European countries: Findings from the PlantLIBRA consumer survey. PLoS ONE. 2014;9:e92265. doi: 10.1371/journal.pone.0092265.", "ArticleIdList": ["10.1371/journal.pone.0092265", "PMC3958487", "24642692"]}, {"Citation": "Peklar J., Henman M.C., Kos M., Richardson K., Kenny R.A. Concurrent use of drugs and supplements in a community-dwelling population aged 50 years or more: Potential benefits and risks. Drugs Aging. 2014;31:527\u2013540. doi: 10.1007/s40266-014-0180-6.", "ArticleIdList": ["10.1007/s40266-014-0180-6", "24890574"]}, {"Citation": "Jeurissen S.M.F., Buurma-Rethans E.J.M., Beukers M.H., Jansen-van der Vliet M., van Rossum C.T.M., Sprong R.C. Consumption of plant food supplements in the Netherlands. Food Funct. 2018;9:179\u2013190. doi: 10.1039/C6FO01174H.", "ArticleIdList": ["10.1039/C6FO01174H", "29184939"]}, {"Citation": "Shaw A., Noble A., Salisbury C., Sharp D., Thompson E., Peters T.J. Predictors of complementary therapy use among asthma patients: Results of a primary care survey. Health Soc. Care Community. 2008;16:155\u2013164. doi: 10.1111/j.1365-2524.2007.00738.x.", "ArticleIdList": ["10.1111/j.1365-2524.2007.00738.x", "18290981"]}, {"Citation": "Marsh J., Hager C., Havey T., Sprague S., Bhandari M., Bryant D. Use of Alternative Medicines by Patients with OA that Adversely Interact with Commonly Prescribed Medications. Clin. Orthop. Relat. Res. 2009;467:2705\u20132722. doi: 10.1007/s11999-009-0764-3.", "ArticleIdList": ["10.1007/s11999-009-0764-3", "PMC2745447", "19255814"]}, {"Citation": "Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community Code Relating to Medicinal Products for Human Use. European Parliament and Council; Brussels, Belgium: 2001. Including Amendments."}, {"Citation": "Bilia A.R., Costa M.D.C. Medicinal plants and their preparations in the European market: Why has the harmonization failed? The cases of St. John\u2019s wort, valerian, ginkgo, ginseng, and green tea. Phytomedicine. 2021;81:153421. doi: 10.1016/j.phymed.2020.153421.", "ArticleIdList": ["10.1016/j.phymed.2020.153421", "33291029"]}, {"Citation": "Fu P.P., Xia Q., Zhao Y., Wang S., Yu H., Chiang H.M. Phototoxicity of herbal plants and herbal products. J. Environ. Sci. Health C Environ. Carcinog Ecotoxicol. Rev. 2013;31:213\u2013255. doi: 10.1080/10590501.2013.824206.", "ArticleIdList": ["10.1080/10590501.2013.824206", "24024520"]}, {"Citation": "Mello A., Melo K.R., Sousa A., Rolim Neto P.J., Silva R. Product indiscriminate use of vitamin risks: A review. Crit. Rev. Food Sci. Nutr. 2020;60:2067\u20132082. doi: 10.1080/10408398.2019.1628003.", "ArticleIdList": ["10.1080/10408398.2019.1628003", "31267771"]}, {"Citation": "Wallace A.W., Amsden G.W. Is it really OK to take this with food? Old interactions with a new twist. J. Clin. Pharmacol. 2002;42:437\u2013443. doi: 10.1177/00912700222011364.", "ArticleIdList": ["10.1177/00912700222011364", "11936569"]}, {"Citation": "Dahmer S., Schiller R.M. Glucosamine. Am. Fam. Physician. 2008;78:471\u2013476.", "ArticleIdList": ["18756654"]}, {"Citation": "Knudsen J.F., Sokol G.H. Potential glucosamine-warfarin interaction resulting in increased international normalized ratio: Case report and review of the literature and MedWatch database. Pharmacotherapy. 2008;28:540\u2013548. doi: 10.1592/phco.28.4.540.", "ArticleIdList": ["10.1592/phco.28.4.540", "18363538"]}, {"Citation": "Langhorst J., Anthonisen I.B., Steder-Neukamm U., L\u00fcdtke R., Spahn G., Michalsen A., Dobos G.J. Amount of systemic steroid medication is a strong predictor for the use of complementary and alternative medicine in patients with inflammatory bowel disease: Results from a German national survey. Inflamm. Bowel Dis. 2005;11:287\u2013295. doi: 10.1097/01.MIB.0000160771.71328.6c.", "ArticleIdList": ["10.1097/01.MIB.0000160771.71328.6c", "15735435"]}, {"Citation": "Chen W., Fitzgerald J.M., Rousseau R., Lynd L.D., Tan W.C., Sadatsafavi M. Complementary and alternative asthma treatments and their association with asthma control: A population-based study. BMJ Open. 2013;3:e003360. doi: 10.1136/bmjopen-2013-003360.", "ArticleIdList": ["10.1136/bmjopen-2013-003360", "PMC3773646", "24005131"]}, {"Citation": "David S., Hamilton J.P. Drug-induced Liver Injury. US Gastroenterol. Hepatol. Rev. 2010;6:73\u201380.", "ArticleIdList": ["PMC3160634", "21874146"]}, {"Citation": "Lucena M.I., Andrade R.J., Kaplowitz N., Garc\u00eda-Cortes M., Fern\u00e1ndez M.C., Romero-Gomez M., Bruguera M., Hallal H., Robles-Diaz M., Rodriguez-Gonz\u00e1lez J.F., et al. Phenotypic characterization of idiosyncratic drug-induced liver injury: The influence of age and sex. Hepatology. 2009;49:2001\u20132009. doi: 10.1002/hep.22895.", "ArticleIdList": ["10.1002/hep.22895", "19475693"]}, {"Citation": "Kucharzik T., Dignass A.U., Atreya R., Bokemeyer B., Esters P., Herrlinger K., Kannengie\u00dfer K., Kienle P., Langhorst J., L\u00fcgering A., et al. S3-Leitlinie Colitis ulcerosa\u2014Living Guideline. Z. Gastroenterol. 2020;58:241\u2013326.", "ArticleIdList": ["33260237"]}, {"Citation": "Matziolis G., Flechtenmacher J., Friederich N., Kessler P., Swoboda W., Baerwald C., Wassilew G., Hube R., Smolenski U., Baraliakos X., et al. S2k-Leitlinie Koxarthrose. AWMF; Berlin, Germany: 2019."}, {"Citation": "Sturm A., Atreya R., Bettenworth D., Bokemeyer B., Digna\u00df A., Ehehalt R., Germer C., Grunert P.C., Helwig U., Herrlinger K., et al. S3-Leitlinie \u201eDiagnostik und Therapie des Morbus Crohn. Z. F\u00fcr Gastroenterol. 2008;46:1094\u20131146.", "ArticleIdList": ["18810679"]}, {"Citation": "LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. National Institute of Diabetes and Digestive and Kidney Diseases; Bethesda, MD, USA: 2012.  [(accessed on 15 November 2021)].  Available online:  https://www.ncbi.nlm.nih.gov/books/NBK547852/", "ArticleIdList": ["31643176"]}, {"Citation": "Canter P.H., Ernst E. Herbal supplement use by persons aged over 50 years in Britain: Frequently used herbs, concomitant use of herbs, nutritional supplements and prescription drugs, rate of informing doctors and potential for negative interactions. Drugs Aging. 2004;21:597\u2013605. doi: 10.2165/00002512-200421090-00004.", "ArticleIdList": ["10.2165/00002512-200421090-00004", "15260514"]}, {"Citation": "Knotek K., Verner V., Chaloupkova P., Kokoska L. Prevalence and use of herbal products in the Czech Republic: Over-the-counter survey among adult pharmacies clients. Complement. Ther. Med. 2012;20:199\u2013206. doi: 10.1016/j.ctim.2011.12.010.", "ArticleIdList": ["10.1016/j.ctim.2011.12.010", "22579431"]}, {"Citation": "Bertomoro P., Renna S., Cottone M., Riegler G., Bossa F., Giglio L., Pastorelli L., Papi C., Castiglione F., Angelucci E., et al. Regional variations in the use of complementary and alternative medicines (CAM) for inflammatory bowel disease patients in Italy: An IG-IBD study. J. Crohn\u2019s Colitis. 2010;4:291\u2013300. doi: 10.1016/j.crohns.2009.12.009.", "ArticleIdList": ["10.1016/j.crohns.2009.12.009", "21122518"]}, {"Citation": "Skiba M.B., Hopkins L.L., Hopkins A.L., Billheimer D., Funk J.L. Nonvitamin, Nonmineral Dietary Supplement Use in Individuals with Rheumatoid Arthritis. J. Nutr. 2020;150:2451\u20132459. doi: 10.1093/jn/nxaa197.", "ArticleIdList": ["10.1093/jn/nxaa197", "PMC7540062", "32805045"]}, {"Citation": "Serpico M.R., Boyle B.M., Kemper K.J., Kim S.C. Complementary and Alternative Medicine Use in Children With Inflammatory Bowel Diseases: A Single-Center Survey. J. Pediatr. Gastroenterol. Nutr. 2016;63:651\u2013657. doi: 10.1097/MPG.0000000000001187.", "ArticleIdList": ["10.1097/MPG.0000000000001187", "26960176"]}, {"Citation": "Hall J.J., Dissanayake T.D., Lau D., Katz S.J. Self-reported use of natural health products among rheumatology patients: A cross-sectional survey. Musculoskelet. Care. 2017;15:345\u2013349. doi: 10.1002/msc.1178.", "ArticleIdList": ["10.1002/msc.1178", "28052563"]}, {"Citation": "Heuschkel R., Afzal N., Wuerth A., Zurakowski D., Leichtner A., Kemper K., Tolia V., Bousvaros A. Complementary medicine use in children and young adults with inflammatory bowel disease. Am. J. Gastroenterol. 2002;97:382\u2013388. doi: 10.1111/j.1572-0241.2002.05474.x.", "ArticleIdList": ["10.1111/j.1572-0241.2002.05474.x", "11866277"]}, {"Citation": "Hilsden R.J., Verhoef M.J., Best A., Pocobelli G. Complementary and alternative medicine use by Canadian patients with inflammatory bowel disease: Results from a national survey. Am. J. Gastroenterol. 2003;98:1563\u20131568. doi: 10.1111/j.1572-0241.2003.07519.x.", "ArticleIdList": ["10.1111/j.1572-0241.2003.07519.x", "12873578"]}, {"Citation": "Joos S., Rosemann T., Szecsenyi J., Hahn E.G., Willich S.N., Brinkhaus B. Use of complementary and alternative medicine in Germany\u2014A survey of patients with inflammatory bowel disease. BMC Complement. Altern. Med. 2006;6:19. doi: 10.1186/1472-6882-6-19.", "ArticleIdList": ["10.1186/1472-6882-6-19", "PMC1539021", "16716218"]}, {"Citation": "Gerasimidis K., McGrogan P., Hassan K., Edwards C.A. Dietary modifications, nutritional supplements and alternative medicine in paediatric patients with inflammatory bowel disease. Aliment. Pharmacol. Ther. 2008;27:155\u2013165. doi: 10.1111/j.1365-2036.2007.03552.x.", "ArticleIdList": ["10.1111/j.1365-2036.2007.03552.x", "17944995"]}, {"Citation": "Fern\u00e1ndez A., Barreiro-de Acosta M., Vallejo N., Iglesias M., Carmona A., Gonz\u00e1lez-Portela C., Lorenzo A., Dom\u00ednguez-Mu\u00f1oz J.E. Complementary and alternative medicine in inflammatory bowel disease patients: Frequency and risk factors. Dig. Liver Dis. 2012;44:904\u2013908. doi: 10.1016/j.dld.2012.06.008.", "ArticleIdList": ["10.1016/j.dld.2012.06.008", "22795615"]}, {"Citation": "Fern\u00e1ndez-Ba\u00f1ares F., Hinojosa J., S\u00e1nchez-Lombra\u00f1a J.L., Navarro E., Mart\u00ednez-Salmer\u00f3n J.F., Garc\u00eda-Pug\u00e9s A., Gonz\u00e1lez-Huix F., Riera J., Gonz\u00e1lez-Lara V., Dom\u00ednguez-Abascal F., et al. Randomized clinical trial of Plantago ovata seeds (dietary fiber) as compared with mesalamine in maintaining remission in ulcerative colitis. Spanish Group for the Study of Crohn\u2019s Disease and Ulcerative Colitis (GETECCU) Am. J. Gastroenterol. 1999;94:427\u2013433. doi: 10.1111/j.1572-0241.1999.872_a.x.", "ArticleIdList": ["10.1111/j.1572-0241.1999.872_a.x", "10022641"]}, {"Citation": "Lang A., Salomon N., Wu J.C., Kopylov U., Lahat A., Har-Noy O., Ching J.Y., Cheong P.K., Avidan B., Gamus D., et al. Curcumin in Combination With Mesalamine Induces Remission in Patients With Mild-to-Moderate Ulcerative Colitis in a Randomized Controlled Trial. Clin. Gastroenterol. Hepatol. 2015;13:1444\u20131449.e1441. doi: 10.1016/j.cgh.2015.02.019.", "ArticleIdList": ["10.1016/j.cgh.2015.02.019", "25724700"]}, {"Citation": "Langhorst J., Varnhagen I., Schneider S.B., Albrecht U., Rueffer A., Stange R., Michalsen A., Dobos G.J. Randomised clinical trial: A herbal preparation of myrrh, chamomile and coffee charcoal compared with mesalazine in maintaining remission in ulcerative colitis--a double-blind, double-dummy study. Aliment. Pharmacol. Ther. 2013;38:490\u2013500. doi: 10.1111/apt.12397.", "ArticleIdList": ["10.1111/apt.12397", "23826890"]}, {"Citation": "Omer B., Krebs S., Omer H., Noor T.O. Steroid-sparing effect of wormwood (Artemisia absinthium) in Crohn\u2019s disease: A double-blind placebo-controlled study. Phytomedicine. 2007;14:87\u201395. doi: 10.1016/j.phymed.2007.01.001.", "ArticleIdList": ["10.1016/j.phymed.2007.01.001", "17240130"]}, {"Citation": "Krebs S., Omer T.N., Omer B. Wormwood (Artemisia absinthium) suppresses tumour necrosis factor alpha and accelerates healing in patients with Crohn\u2019s disease\u2014A controlled clinical trial. Phytomedicine. 2010;17:305\u2013309. doi: 10.1016/j.phymed.2009.10.013.", "ArticleIdList": ["10.1016/j.phymed.2009.10.013", "19962291"]}, {"Citation": "Lowin T., Schneider M., Pongratz G. Joints for joints: Cannabinoids in the treatment of rheumatoid arthritis. Curr. Opin. Rheumatol. 2019;31:271\u2013278. doi: 10.1097/BOR.0000000000000590.", "ArticleIdList": ["10.1097/BOR.0000000000000590", "30920973"]}, {"Citation": "Gusho C.A., Court T. Cannabidiol: A Brief Review of Its Therapeutic and Pharmacologic Efficacy in the Management of Joint Disease. Cureus. 2020;12:e7375. doi: 10.7759/cureus.7375.", "ArticleIdList": ["10.7759/cureus.7375", "PMC7176325", "32328386"]}, {"Citation": "Neufeld T., Pfuhlmann K., Stock-Schr\u00f6er B., Kairey L., Bauer N., H\u00e4user W., Langhorst J. Cannabis use of patients with inflammatory bowel disease in Germany: A cross-sectional survey. Z. Gastroenterol. 2021;59:1068\u20131077. doi: 10.1055/a-1400-2768.", "ArticleIdList": ["10.1055/a-1400-2768", "34157755"]}, {"Citation": "Katz D., Katz I., Porat-Katz B.S., Shoenfeld Y. Medical cannabis: Another piece in the mosaic of autoimmunity? Clin. Pharmacol. Ther. 2017;101:230\u2013238. doi: 10.1002/cpt.568.", "ArticleIdList": ["10.1002/cpt.568", "27859024"]}, {"Citation": "Schneider M., Baseler G., Funken O., Heberger S., Kiltz U., Klose P., Kr\u00fcger K., Langhorst J., Mau W., Oltman R., et al. S3-Leitlinie Interdisziplin\u00e4re Leitlinie Management der Fr\u00fchen Rheumatoiden Arthritis. AWMF; Berlin, Germany: 2019.", "ArticleIdList": ["32504239"]}, {"Citation": "St\u00f6ve J., Bock F., B\u00f6hle E., Dau W., Flechtenmacher J., Graichen H., Greitemann B., Grifka J., Halder A., Jerosch J., et al. S2K-Leitlinie Gonarthrose. AWMF; Berlin, Germany: 2020."}, {"Citation": "Fiehn C., Holle J., Iking-Konert C., Leipe J., Weseloh C., Marc Frerix M., Alten R., Behrens F., Baerwald C., Braun J., et al. 2e-Leitline: Therapie der Rheumatoiden Arthritis Mit Krankheitsmodifizierenden Medikamenten. AWMF; Berlin, Germany: 2018.", "ArticleIdList": ["29968101"]}, {"Citation": "Keizer R.J., Huitema A.D., Schellens J.H., Beijnen J.H. Clinical pharmacokinetics of therapeutic monoclonal antibodies. Clin. Pharmacokinet. 2010;49:493\u2013507. doi: 10.2165/11531280-000000000-00000.", "ArticleIdList": ["10.2165/11531280-000000000-00000", "20608753"]}, {"Citation": "Hansel T.T., Kropshofer H., Singer T., Mitchell J.A., George A.J. The safety and side effects of monoclonal antibodies. Nat. Rev. Drug Discov. 2010;9:325\u2013338. doi: 10.1038/nrd3003.", "ArticleIdList": ["10.1038/nrd3003", "20305665"]}, {"Citation": "Brune K., Renner B., Tiegs G. Acetaminophen/paracetamol: A history of errors, failures and false decisions. Eur. J. Pain. 2015;19:953\u2013965. doi: 10.1002/ejp.621.", "ArticleIdList": ["10.1002/ejp.621", "25429980"]}, {"Citation": "Abebe W. Herbal medication: Potential for adverse interactions with analgesic drugs. J. Clin. Pharm. Ther. 2002;27:391\u2013401. doi: 10.1046/j.1365-2710.2002.00444.x.", "ArticleIdList": ["10.1046/j.1365-2710.2002.00444.x", "12472978"]}, {"Citation": "Aboonabi A., Meyer R.R., Gaiz A., Singh I. Anthocyanins in berries exhibited anti-atherogenicity and antiplatelet activities in a metabolic syndrome population. Nutr. Res. 2020;76:82\u201393. doi: 10.1016/j.nutres.2020.02.011.", "ArticleIdList": ["10.1016/j.nutres.2020.02.011", "32217379"]}, {"Citation": "European Unionherbal Monograph on Menyanthes trifoliata L., Folium. Committee on Herbal Medicinal Products (HMPC), European Medicines Agency; Amstersam, The Netherlands: 2021."}, {"Citation": "Frank A., Unger M. Analysis of frankincense from various Boswellia species with inhibitory activity on human drug metabolising cytochrome P450 enzymes using liquid chromatography mass spectrometry after automated on-line extraction. J. Chromatogr. A. 2006;1112:255\u2013262. doi: 10.1016/j.chroma.2005.11.116.", "ArticleIdList": ["10.1016/j.chroma.2005.11.116", "16364338"]}, {"Citation": "Kr\u00fcger P., Kanzer J., Hummel J., Fricker G., Schubert-Zsilavecz M., Abdel-Tawab M. Permeation of Boswellia extract in the Caco-2 model and possible interactions of its constituents KBA and AKBA with OATP1B3 and MRP2. Eur. J. Pharm. Sci. 2009;36:275\u2013284. doi: 10.1016/j.ejps.2008.10.005.", "ArticleIdList": ["10.1016/j.ejps.2008.10.005", "19010411"]}, {"Citation": "Weber C.C., Reising K., M\u00fcller W.E., Schubert-Zsilavecz M., Abdel-Tawab M. Modulation of Pgp function by boswellic acids. Planta Med. 2006;72:507\u2013513. doi: 10.1055/s-2006-931536.", "ArticleIdList": ["10.1055/s-2006-931536", "16773534"]}, {"Citation": "Paoletti A., Gallo E., Benemei S., Vietri M., Lapi F., Volpi R., Menniti-Ippolito F., Gori L., Mugelli A., Firenzuoli F., et al. Interactions between Natural Health Products and Oral Anticoagulants: Spontaneous Reports in the Italian Surveillance System of Natural Health Products. Evid.-Based Complement. Altern. Med. 2011;2011:612150. doi: 10.1155/2011/612150.", "ArticleIdList": ["10.1155/2011/612150", "PMC3025393", "21274401"]}, {"Citation": "Sativex Spray [Prescription Information], GW Pharma (International), Amersfoort, The Netherlands. B.V. Almirall Hermal GmbH; Reinbek, Germany: 2020."}, {"Citation": "Jusko W.J., Schentag J.J., Clark J.H., Gardner M., Yurchak A.M. Enhanced biotransformation of theophylline in marihuana and tobacco smokers. Clin. Pharmacol. Ther. 1978;24:405\u2013410. doi: 10.1002/cpt1978244406.", "ArticleIdList": ["10.1002/cpt1978244406", "688731"]}, {"Citation": "Nasrin S., Watson C.J.W., Perez-Paramo Y.X., Lazarus P. Cannabinoid Metabolites as Inhibitors of Major Hepatic CYP450 Enzymes, with Implications for Cannabis-Drug Interactions. Drug Metab. Dispos. 2021;49:1070\u20131080. doi: 10.1124/dmd.121.000442.", "ArticleIdList": ["10.1124/dmd.121.000442", "34493602"]}, {"Citation": "Leino A.D., Emoto C., Fukuda T., Privitera M., Vinks A.A., Alloway R.R. Evidence of a clinically significant drug-drug interaction between cannabidiol and tacrolimus. Am. J. Transplant. 2019;19:2944\u20132948. doi: 10.1111/ajt.15398.", "ArticleIdList": ["10.1111/ajt.15398", "31012522"]}, {"Citation": "Feltrin C., Farias I.V., Sandjo L.P., Reginatto F.H., Sim\u00f5es C.M.O. Effects of Standardized Medicinal Plant Extracts on Drug Metabolism Mediated by CYP3A4 and CYP2D6 Enzymes. Chem. Res. Toxicol. 2020;33:2408\u20132419. doi: 10.1021/acs.chemrestox.0c00182.", "ArticleIdList": ["10.1021/acs.chemrestox.0c00182", "32786546"]}, {"Citation": "Goldstein L.H., Elias M., Ron-Avraham G., Biniaurishvili B.Z., Madjar M., Kamargash I., Braunstein R., Berkovitch M., Golik A. Consumption of herbal remedies and dietary supplements amongst patients hospitalized in medical wards. Br. J. Clin. Pharmacol. 2007;64:373\u2013380. doi: 10.1111/j.1365-2125.2007.02878.x.", "ArticleIdList": ["10.1111/j.1365-2125.2007.02878.x", "PMC2000642", "17425631"]}, {"Citation": "Nowack R., Nowak B. Herbal teas interfere with cyclosporin levels in renal transplant patients. Nephrol. Dial. Transplant. 2005;20:2554\u20132556. doi: 10.1093/ndt/gfi003.", "ArticleIdList": ["10.1093/ndt/gfi003", "16046518"]}, {"Citation": "Zikria J., Goldman R., Ansell J. Cranberry juice and warfarin: When bad publicity trumps science. Am. J. Med. 2010;123:384\u2013392. doi: 10.1016/j.amjmed.2009.08.019.", "ArticleIdList": ["10.1016/j.amjmed.2009.08.019", "20399311"]}, {"Citation": "Dave A.A., Samuel J. Suspected Interaction of Cranberry Juice Extracts and Tacrolimus Serum Levels: A Case Report. Cureus. 2016;8:e610. doi: 10.7759/cureus.610.", "ArticleIdList": ["10.7759/cureus.610", "PMC4911337", "27335715"]}, {"Citation": "European Union Herbal Monograph on Linum usitatissimum L., Semen. Committee on Herbal Medicinal Products (HMPC), European Medicines Agency; Amstersam, The Netherlands: 2015."}, {"Citation": "Gurley B.J., Gardner S.F., Hubbard M.A., Williams D.K., Gentry W.B., Cui Y., Ang C.Y. Clinical assessment of effects of botanical supplementation on cytochrome P450 phenotypes in the elderly: St John\u2019s wort, garlic oil, Panax ginseng and Ginkgo biloba. Drugs Aging. 2005;22:525\u2013539. doi: 10.2165/00002512-200522060-00006.", "ArticleIdList": ["10.2165/00002512-200522060-00006", "PMC1858666", "15974642"]}, {"Citation": "Markowitz J.S., Devane C.L., Chavin K.D., Taylor R.M., Ruan Y., Donovan J.L. Effects of garlic (Allium sativum L.) supplementation on cytochrome P450 2D6 and 3A4 activity in healthy volunteers. Clin. Pharmacol. Ther. 2003;74:170\u2013177. doi: 10.1016/S0009-9236(03)00148-6.", "ArticleIdList": ["10.1016/S0009-9236(03)00148-6", "12891227"]}, {"Citation": "Hajda J., Rentsch K.M., Gubler C., Steinert H., Stieger B., Fattinger K. Garlic extract induces intestinal P-glycoprotein, but exhibits no effect on intestinal and hepatic CYP3A4 in humans. Eur. J. Pharm. Sci. 2010;41:729\u2013735. doi: 10.1016/j.ejps.2010.09.016.", "ArticleIdList": ["10.1016/j.ejps.2010.09.016", "20933082"]}, {"Citation": "Beckert B.W., Concannon M.J., Henry S.L., Smith D.S., Puckett C.L. The effect of herbal medicines on platelet function: An in vivo experiment and review of the literature. Plast. Reconstr. Surg. 2007;120:2044\u20132050. doi: 10.1097/01.prs.0000295972.18570.0b.", "ArticleIdList": ["10.1097/01.prs.0000295972.18570.0b", "18090773"]}, {"Citation": "Mohammed Abdul M.I., Jiang X., Williams K.M., Day R.O., Roufogalis B.D., Liauw W.S., Xu H., McLachlan A.J. Pharmacodynamic interaction of warfarin with cranberry but not with garlic in healthy subjects. Br. J. Pharmacol. 2008;154:1691\u20131700. doi: 10.1038/bjp.2008.210.", "ArticleIdList": ["10.1038/bjp.2008.210", "PMC2518459", "18516070"]}, {"Citation": "Kim I.S., Kim S.Y., Yoo H.H. Effects of an aqueous-ethanolic extract of ginger on cytochrome P450 enzyme-mediated drug metabolism. Pharmazie. 2012;67:1007\u20131009.", "ArticleIdList": ["23346764"]}, {"Citation": "Kimura Y., Ito H., Hatano T. Effects of mace and nutmeg on human cytochrome P450 3A4 and 2C9 activity. Biol. Pharm. Bull. 2010;33:1977\u20131982. doi: 10.1248/bpb.33.1977.", "ArticleIdList": ["10.1248/bpb.33.1977", "21139236"]}, {"Citation": "Loretz C., Ho M.D., Alam N., Mitchell W., Li A.P. Application of Cryopreserved Human Intestinal Mucosa and Cryopreserved Human Enterocytes in the Evaluation of Herb-Drug Interactions: Evaluation of CYP3A Inhibitory Potential of Grapefruit Juice and Commercial Formulations of Twenty-Nine Herbal Supplements. Drug Metab. Dispos. 2020;48:1084\u20131091. doi: 10.1124/dmd.120.000033.", "ArticleIdList": ["10.1124/dmd.120.000033", "32719085"]}, {"Citation": "Maadarani O., Bitar Z., Mohsen M. Adding Herbal Products to Direct-Acting Oral Anticoagulants Can Be Fatal. Eur. J. Case Rep. Intern. Med. 2019;6:001190. doi: 10.12890/2019_001190.", "ArticleIdList": ["10.12890/2019_001190", "PMC6726349", "31508385"]}, {"Citation": "Kr\u00fcth P., Brosi E., Fux R., M\u00f6rike K., Gleiter C.H. Ginger-associated overanticoagulation by phenprocoumon. Ann. Pharmacother. 2004;38:257\u2013260. doi: 10.1345/aph.1D225.", "ArticleIdList": ["10.1345/aph.1D225", "14742762"]}, {"Citation": "Revol B., Gautier-Veyret E., Arriv\u00e9 C., Fouilh\u00e9 Sam-La\u00ef N., McLeer-Florin A., Pluchart H., Pinsolle J., Toffart A.C. Pharmacokinetic herb-drug interaction between ginger and crizotinib. Br. J. Clin. Pharmacol. 2020;86:1892\u20131893. doi: 10.1111/bcp.13862.", "ArticleIdList": ["10.1111/bcp.13862", "PMC7444772", "30701569"]}, {"Citation": "Jiang X., Williams K.M., Liauw W.S., Ammit A.J., Roufogalis B.D., Duke C.C., Day R.O., McLachlan A.J. Effect of ginkgo and ginger on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects. Br. J. Clin. Pharmacol. 2005;59:425\u2013432. doi: 10.1111/j.1365-2125.2005.02322.x.", "ArticleIdList": ["10.1111/j.1365-2125.2005.02322.x", "PMC1884814", "15801937"]}, {"Citation": "Egashira K., Sasaki H., Higuchi S., Ieiri I. Food-drug interaction of tacrolimus with pomelo, ginger, and turmeric juice in rats. Drug Metab. Pharmacokinet. 2012;27:242\u2013247. doi: 10.2133/dmpk.DMPK-11-RG-105.", "ArticleIdList": ["10.2133/dmpk.DMPK-11-RG-105", "22123127"]}, {"Citation": "Liao Y.R., Leu Y.L., Chan Y.Y., Kuo P.C., Wu T.S. Anti-platelet aggregation and vasorelaxing effects of the constituents of the rhizomes of Zingiber officinale. Molecules. 2012;17:8928\u20138937. doi: 10.3390/molecules17088928.", "ArticleIdList": ["10.3390/molecules17088928", "PMC6268115", "22836212"]}, {"Citation": "Nishikawa M., Ariyoshi N., Kotani A., Ishii I., Nakamura H., Nakasa H., Ida M., Nakamura H., Kimura N., Kimura M., et al. Effects of continuous ingestion of green tea or grape seed extracts on the pharmacokinetics of midazolam. Drug Metab. Pharmacokinet. 2004;19:280\u2013289. doi: 10.2133/dmpk.19.280.", "ArticleIdList": ["10.2133/dmpk.19.280", "15499196"]}, {"Citation": "Goey A.K., Meijerman I., Beijnen J.H., Schellens J.H. The effect of grape seed extract on the pharmacokinetics of dextromethorphan in healthy volunteers. Eur. J. Clin. Pharmacol. 2013;69:1883\u20131890. doi: 10.1007/s00228-013-1558-9.", "ArticleIdList": ["10.1007/s00228-013-1558-9", "23881421"]}, {"Citation": "Mohamed M.E., Frye R.F. Inhibitory effects of commonly used herbal extracts on UDP-glucuronosyltransferase 1A4, 1A6, and 1A9 enzyme activities. Drug Metab. Dispos. 2011;39:1522\u20131528. doi: 10.1124/dmd.111.039602.", "ArticleIdList": ["10.1124/dmd.111.039602", "PMC3164271", "21632963"]}, {"Citation": "Gurley B., Hubbard M.A., Williams D.K., Thaden J., Tong Y., Gentry W.B., Breen P., Carrier D.J., Cheboyina S. Assessing the clinical significance of botanical supplementation on human cytochrome P450 3A activity: Comparison of a milk thistle and black cohosh product to rifampin and clarithromycin. J. Clin. Pharmacol. 2006;46:201\u2013213. doi: 10.1177/0091270005284854.", "ArticleIdList": ["10.1177/0091270005284854", "PMC1865122", "16432272"]}, {"Citation": "Gurley B.J., Gardner S.F., Hubbard M.A., Williams D.K., Gentry W.B., Carrier J., Khan I.A., Edwards D.J., Shah A. In vivo assessment of botanical supplementation on human cytochrome P450 phenotypes: Citrus aurantium, Echinacea purpurea, milk thistle, and saw palmetto. Clin. Pharmacol. Ther. 2004;76:428\u2013440. doi: 10.1016/j.clpt.2004.07.007.", "ArticleIdList": ["10.1016/j.clpt.2004.07.007", "15536458"]}, {"Citation": "Van Erp N.P., Baker S.D., Zhao M., Rudek M.A., Guchelaar H.J., Nortier J.W., Sparreboom A., Gelderblom H. Effect of milk thistle (Silybum marianum) on the pharmacokinetics of irinotecan. Clin. Cancer Res. 2005;11:7800\u20137806. doi: 10.1158/1078-0432.CCR-05-1288.", "ArticleIdList": ["10.1158/1078-0432.CCR-05-1288", "16278402"]}, {"Citation": "Fuhr U., Beckmann-Knopp S., Jetter A., L\u00fcck H., Mengs U. The effect of silymarin on oral nifedipine pharmacokinetics. Planta Med. 2007;73:1429\u20131435. doi: 10.1055/s-2007-990256.", "ArticleIdList": ["10.1055/s-2007-990256", "17968815"]}, {"Citation": "Kawaguchi-Suzuki M., Frye R.F., Zhu H.J., Brinda B.J., Chavin K.D., Bernstein H.J., Markowitz J.S. The effects of milk thistle (Silybum marianum) on human cytochrome P450 activity. Drug Metab. Dispos. 2014;42:1611\u20131616. doi: 10.1124/dmd.114.057232.", "ArticleIdList": ["10.1124/dmd.114.057232", "PMC4164972", "25028567"]}, {"Citation": "Lash D.B., Ward S. CYP2C9-mediated warfarin and milk thistle interaction. J. Clin. Pharm. Ther. 2020;45:368\u2013369. doi: 10.1111/jcpt.13064.", "ArticleIdList": ["10.1111/jcpt.13064", "31633199"]}, {"Citation": "MYRRHINIL-INTEST [Prescription Information], Langenhagen, Repha GmbH. June 2018.  [(accessed on 2 November 2021)].  Available online:  www.fachinfo.de."}, {"Citation": "Brobst D.E., Ding X., Creech K.L., Goodwin B., Kelley B., Staudinger J.L. Guggulsterone activates multiple nuclear receptors and induces CYP3A gene expression through the pregnane X receptor. J. Pharmacol. Exp. Ther. 2004;310:528\u2013535. doi: 10.1124/jpet.103.064329.", "ArticleIdList": ["10.1124/jpet.103.064329", "15075359"]}, {"Citation": "Kobayashi T., Sugaya K., Onose J.I., Abe N. Peppermint (Mentha piperita L.) extract effectively inhibits cytochrome P450 3A4 (CYP3A4) mRNA induction in rifampicin-treated HepG2 cells. Biosci. Biotechnol. Biochem. 2019;83:1181\u20131192. doi: 10.1080/09168451.2019.1608802.", "ArticleIdList": ["10.1080/09168451.2019.1608802", "31032736"]}, {"Citation": "Unger M., Frank A. Simultaneous determination of the inhibitory potency of herbal extracts on the activity of six major cytochrome P450 enzymes using liquid chromatography/mass spectrometry and automated online extraction. Rapid Commun. Mass Spectrom. 2004;18:2273\u20132281. doi: 10.1002/rcm.1621.", "ArticleIdList": ["10.1002/rcm.1621", "15384148"]}, {"Citation": "Sato Y., Sasaki T., Takahashi S., Kumagai T., Nagata K. Development of a highly reproducible system to evaluate inhibition of cytochrome P450 3A4 activity by natural medicines. J. Pharm. Pharm. Sci. 2015;18:316\u2013327. doi: 10.18433/J3VK5G.", "ArticleIdList": ["10.18433/J3VK5G", "26626238"]}, {"Citation": "Wacher V.J., Wong S., Wong H.T. Peppermint oil enhances cyclosporine oral bioavailability in rats: Comparison with D-alpha-tocopheryl poly(ethylene glycol 1000) succinate (TPGS) and ketoconazole. J. Pharm. Sci. 2002;91:77\u201390. doi: 10.1002/jps.10008.", "ArticleIdList": ["10.1002/jps.10008", "11782899"]}, {"Citation": "Community Herbal Monograph on Plantago afra L. et Plantago indica L., Semen. Committee on Herbal Medicinal Products (HMPC), European Medicines Agency; Amstersam, The Netherlands: 2013."}, {"Citation": "Ahi S., Esmaeilzadeh M., Kayvanpour E., Sedaghat-Hamedani F., Samadanifard S.H. A bulking agent may lead to adrenal insufficiency crisis: A case report. Acta Med. Iran. 2011;49:688\u2013689.", "ArticleIdList": ["22071646"]}, {"Citation": "Cheema P., El-Mefty O., Jazieh A.R. Intraoperative haemorrhage associated with the use of extract of Saw Palmetto herb: A case report and review of literature. J. Intern. Med. 2001;250:167\u2013169. doi: 10.1046/j.1365-2796.2001.00851.x.", "ArticleIdList": ["10.1046/j.1365-2796.2001.00851.x", "11489067"]}, {"Citation": "Agbabiaka T.B., Pittler M.H., Wider B., Ernst E. Serenoa repens (saw palmetto): A systematic review of adverse events. Drug Saf. 2009;32:637\u2013647. doi: 10.2165/00002018-200932080-00003.", "ArticleIdList": ["10.2165/00002018-200932080-00003", "19591529"]}, {"Citation": "Markowitz J.S., Donovan J.L., Devane C.L., Taylor R.M., Ruan Y., Wang J.S., Chavin K.D. Multiple doses of saw palmetto (Serenoa repens) did not alter cytochrome P450 2D6 and 3A4 activity in normal volunteers. Clin. Pharmacol. Ther. 2003;74:536\u2013542. doi: 10.1016/j.clpt.2003.08.010.", "ArticleIdList": ["10.1016/j.clpt.2003.08.010", "14663456"]}, {"Citation": "Izzo A.A., Ernst E. Interactions between herbal medicines and prescribed drugs: An updated systematic review. Drugs. 2009;69:1777\u20131798. doi: 10.2165/11317010-000000000-00000.", "ArticleIdList": ["10.2165/11317010-000000000-00000", "19719333"]}, {"Citation": "Su Z., Zhang B., Zhu W., Du Z. In silico and in vivo evaluation of flavonoid extracts on CYP2D6-mediated herb-drug interaction. J. Mol. Model. 2012;18:4657\u20134663. doi: 10.1007/s00894-012-1472-6.", "ArticleIdList": ["10.1007/s00894-012-1472-6", "22648787"]}, {"Citation": "Community Herbal Monograph on Hypericum perforatum L., Herba (Well-Established Medicinal USE) Committee on Herbal Medicinal Products (HMPC), European Medicines Agency; Amstersam, The Netherlands: 2009."}, {"Citation": "Borrelli F., Izzo A.A. Herb-drug interactions with St John\u2019s wort (Hypericum perforatum): An update on clinical observations. AAPS J. 2009;11:710\u2013727. doi: 10.1208/s12248-009-9146-8.", "ArticleIdList": ["10.1208/s12248-009-9146-8", "PMC2782080", "19859815"]}, {"Citation": "Donovan J.L., DeVane C.L., Chavin K.D., Wang J.S., Gibson B.B., Gefroh H.A., Markowitz J.S. Multiple night-time doses of valerian (Valeriana officinalis) had minimal effects on CYP3A4 activity and no effect on CYP2D6 activity in healthy volunteers. Drug Metab. Dispos. 2004;32:1333\u20131336. doi: 10.1124/dmd.104.001164.", "ArticleIdList": ["10.1124/dmd.104.001164", "15328251"]}, {"Citation": "Gurley B.J., Gardner S.F., Hubbard M.A., Williams D.K., Gentry W.B., Khan I.A., Shah A. In vivo effects of goldenseal, kava kava, black cohosh, and valerian on human cytochrome P450 1A2, 2D6, 2E1, and 3A4/5 phenotypes. Clin. Pharmacol. Ther. 2005;77:415\u2013426. doi: 10.1016/j.clpt.2005.01.009.", "ArticleIdList": ["10.1016/j.clpt.2005.01.009", "PMC1894911", "15900287"]}, {"Citation": "Kelber O., Nieber K., Kraft K. Valerian: No evidence for clinically relevant interactions. Evid.-Based Complement. Altern. Med. 2014;2014:879396. doi: 10.1155/2014/879396.", "ArticleIdList": ["10.1155/2014/879396", "PMC4100259", "25093031"]}, {"Citation": "Lin H., Honglang L., Weifeng L., Junmin C., Jiantao Y., Junjing G. The mechanism of alopolysaccharide protecting ulceralive colitis. Biomed. Pharmacother. 2017;88:145\u2013150. doi: 10.1016/j.biopha.2016.11.138.", "ArticleIdList": ["10.1016/j.biopha.2016.11.138", "28103508"]}, {"Citation": "Van Gorkom B.A., de Vries E.G., Karrenbeld A., Kleibeuker J.H. Review article: Anthranoid laxatives and their potential carcinogenic effects. Aliment. Pharmacol. Ther. 1999;13:443\u2013452. doi: 10.1046/j.1365-2036.1999.00468.x.", "ArticleIdList": ["10.1046/j.1365-2036.1999.00468.x", "10215727"]}, {"Citation": "Shia C.S., Juang S.H., Tsai S.Y., Lee Chao P.D., Hou Y.C. Interaction of rhubarb and methotrexate in rats: In vivo and ex vivo approaches. Am. J. Chin. Med. 2013;41:1427\u20131438. doi: 10.1142/S0192415X1350095X.", "ArticleIdList": ["10.1142/S0192415X1350095X", "24228610"]}, {"Citation": "Lee J., Lee M.S., Nam K.W. Acute toxic hepatitis caused by an aloe vera preparation in a young patient: A case report with a literature review. Korean J. Gastroenterol. 2014;64:54\u201358. doi: 10.4166/kjg.2014.64.1.54.", "ArticleIdList": ["10.4166/kjg.2014.64.1.54", "25073673"]}, {"Citation": "Yang H.N., Kim D.J., Kim Y.M., Kim B.H., Sohn K.M., Choi M.J., Choi Y.H. Aloe-induced toxic hepatitis. J. Korean Med. Sci. 2010;25:492\u2013495. doi: 10.3346/jkms.2010.25.3.492.", "ArticleIdList": ["10.3346/jkms.2010.25.3.492", "PMC2826749", "20191055"]}, {"Citation": "Parlati L., Voican C.S., Perlemuter K., Perlemuter G. Aloe vera-induced acute liver injury: A case report and literature review. Clin. Res. Hepatol. Gastroenterol. 2017;41:e39\u2013e42. doi: 10.1016/j.clinre.2016.10.002.", "ArticleIdList": ["10.1016/j.clinre.2016.10.002", "27856182"]}, {"Citation": "Bottenberg M.M., Wall G.C., Harvey R.L., Habib S. Oral aloe vera-induced hepatitis. Ann. Pharmacother. 2007;41:1740\u20131743. doi: 10.1345/aph.1K132.", "ArticleIdList": ["10.1345/aph.1K132", "17726067"]}, {"Citation": "Ballotin V.R., Bigarella L.G., Brand\u00e3o A.B.M., Balbinot R.A., Balbinot S.S., Soldera J. Herb-induced liver injury: Systematic review and meta-analysis. World J. Clin. Cases. 2021;9:5490\u20135513. doi: 10.12998/wjcc.v9.i20.5490.", "ArticleIdList": ["10.12998/wjcc.v9.i20.5490", "PMC8281430", "34307603"]}, {"Citation": "Haasbroek A., Willers C., Glyn M., du Plessis L., Hamman J. Intestinal Drug Absorption Enhancement by Aloe vera Gel and Whole Leaf Extract: In Vitro Investigations into the Mechanisms of Action. Pharmaceutics. 2019;11:36. doi: 10.3390/pharmaceutics11010036.", "ArticleIdList": ["10.3390/pharmaceutics11010036", "PMC6359586", "30669246"]}, {"Citation": "Russo E., Guy G.W. A tale of two cannabinoids: The therapeutic rationale for combining tetrahydrocannabinol and cannabidiol. Med. Hypotheses. 2006;66:234\u2013246. doi: 10.1016/j.mehy.2005.08.026.", "ArticleIdList": ["10.1016/j.mehy.2005.08.026", "16209908"]}, {"Citation": "Russo E.B. Taming THC: Potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. Br. J. Pharmacol. 2011;163:1344\u20131364. doi: 10.1111/j.1476-5381.2011.01238.x.", "ArticleIdList": ["10.1111/j.1476-5381.2011.01238.x", "PMC3165946", "21749363"]}, {"Citation": "Lowin T., Tingting R., Zurmahr J., Classen T., Schneider M., Pongratz G. Cannabidiol (CBD): A killer for inflammatory rheumatoid arthritis synovial fibroblasts. Cell Death Dis. 2020;11:714. doi: 10.1038/s41419-020-02892-1.", "ArticleIdList": ["10.1038/s41419-020-02892-1", "PMC7463000", "32873774"]}, {"Citation": "Grill M., Hasenoehrl C., Storr M., Schicho R. Medical Cannabis and Cannabinoids: An Option for the Treatment of Inflammatory Bowel Disease and Cancer of the Colon? Med. Cannabis Cannabinoids. 2018;1:28\u201335. doi: 10.1159/000489036.", "ArticleIdList": ["10.1159/000489036", "PMC8489318", "34676319"]}, {"Citation": "Doohan P.T., Oldfield L.D., Arnold J.C., Anderson L.L. Cannabinoid Interactions with Cytochrome P450 Drug Metabolism: A Full-Spectrum Characterization. AAPS J. 2021;23:91. doi: 10.1208/s12248-021-00616-7.", "ArticleIdList": ["10.1208/s12248-021-00616-7", "34181150"]}, {"Citation": "Nasrin S., Watson C.J.W., Bardhi K., Fort G., Chen G., Lazarus P. Inhibition of UDP-Glucuronosyltransferase Enzymes by Major Cannabinoids and Their Metabolites. Drug Metab. Dispos. 2021;49:1081\u20131089. doi: 10.1124/dmd.121.000530.", "ArticleIdList": ["10.1124/dmd.121.000530", "34493601"]}, {"Citation": "European Union Herbal Monograph on Harpagophytum Procumbens DC. And/or Harpagophytum zeyheri Decne, Radix. Committee on Herbal Medicinal Products (HMPC), European Medicines Agency; Amstersam, The Netherlands: 2016."}, {"Citation": "Menghini L., Recinella L., Leone S., Chiavaroli A., Cicala C., Brunetti L., Vladimir-Kne\u017eevi\u0107 S., Orlando G., Ferrante C. Devil\u2019s claw (Harpagophytum procumbens) and chronic inflammatory diseases: A concise overview on preclinical and clinical data. Phytother. Res. 2019;33:2152\u20132162. doi: 10.1002/ptr.6395.", "ArticleIdList": ["10.1002/ptr.6395", "31273865"]}, {"Citation": "Anauate M.C., Torres L.M., de Mello S.B. Effect of isolated fractions of Harpagophytum procumbens D.C. (devil\u2019s claw) on COX-1, COX-2 activity and nitric oxide production on whole-blood assay. Phytother. Res. 2010;24:1365\u20131369. doi: 10.1002/ptr.3124.", "ArticleIdList": ["10.1002/ptr.3124", "20812280"]}, {"Citation": "Vlachojannis J., Roufogalis B.D., Chrubasik S. Systematic review on the safety of Harpagophytum preparations for osteoarthritic and low back pain. Phytother. Res. 2008;22:149\u2013152. doi: 10.1002/ptr.2314.", "ArticleIdList": ["10.1002/ptr.2314", "18236448"]}, {"Citation": "Romiti N., Tramonti G., Corti A., Chieli E. Effects of Devil\u2019s Claw (Harpagophytum procumbens) on the multidrug transporter ABCB1/P-glycoprotein. Phytomedicine. 2009;16:1095\u20131100. doi: 10.1016/j.phymed.2009.05.001.", "ArticleIdList": ["10.1016/j.phymed.2009.05.001", "19577448"]}, {"Citation": "Rahman H., Kim M., Leung G., Green J.A., Katz S. Drug-Herb Interactions in the Elderly Patient with IBD: A Growing Concern. Curr. Treat. Options Gastroenterol. 2017;15:618\u2013636. doi: 10.1007/s11938-017-0154-y.", "ArticleIdList": ["10.1007/s11938-017-0154-y", "28918484"]}, {"Citation": "Modarai M., Suter A., Kortenkamp A., Heinrich M. The interaction potential of herbal medicinal products: A luminescence-based screening platform assessing effects on cytochrome P450 and its use with devil\u2019s claw (Harpagophyti radix) preparations. J. Pharm. Pharmacol. 2011;63:429\u2013438. doi: 10.1111/j.2042-7158.2010.01235.x.", "ArticleIdList": ["10.1111/j.2042-7158.2010.01235.x", "21749392"]}, {"Citation": "Hinz B., Renner B., Brune K. Drug insight: Cyclo-oxygenase-2 inhibitors--a critical appraisal. Nat. Clin. Pract. Rheumatol. 2007;3:552\u2013560. doi: 10.1038/ncprheum0619. quiz 551 p following 589.", "ArticleIdList": ["10.1038/ncprheum0619", "17906610"]}, {"Citation": "Toselli F., Matthias A., Gillam E.M. Echinacea metabolism and drug interactions: The case for standardization of a complementary medicine. Life Sci. 2009;85:97\u2013106. doi: 10.1016/j.lfs.2009.04.023.", "ArticleIdList": ["10.1016/j.lfs.2009.04.023", "19427870"]}, {"Citation": "Ardjomand-Woelkart K., Bauer R. Review and Assessment of Medicinal Safety Data of Orally Used Echinacea Preparations. Planta Med. 2016;82:17\u201331. doi: 10.1055/s-0035-1558096.", "ArticleIdList": ["10.1055/s-0035-1558096", "26441065"]}, {"Citation": "Hansen T.S., Nilsen O.G. In vitro CYP3A4 metabolism: Inhibition by Echinacea purpurea and choice of substrate for the evaluation of herbal inhibition. Basic Clin. Pharmacol. Toxicol. 2008;103:445\u2013449. doi: 10.1111/j.1742-7843.2008.00307.x.", "ArticleIdList": ["10.1111/j.1742-7843.2008.00307.x", "18947363"]}, {"Citation": "Bossaer J.B., Odle B.L. Probable etoposide interaction with Echinacea. J. Diet. Suppl. 2012;9:90\u201395. doi: 10.3109/19390211.2012.682643.", "ArticleIdList": ["10.3109/19390211.2012.682643", "22607644"]}, {"Citation": "Awortwe C., Manda V.K., Avonto C., Khan S.I., Khan I.A., Walker L.A., Bouic P.J., Rosenkranz B. Echinacea purpurea up-regulates CYP1A2, CYP3A4 and MDR1 gene expression by activation of pregnane X receptor pathway. Xenobiotica. 2015;45:218\u2013229. doi: 10.3109/00498254.2014.973930.", "ArticleIdList": ["10.3109/00498254.2014.973930", "PMC4355449", "25377539"]}, {"Citation": "Gorski J.C., Huang S.M., Pinto A., Hamman M.A., Hilligoss J.K., Zaheer N.A., Desai M., Miller M., Hall S.D. The effect of echinacea (Echinacea purpurea root) on cytochrome P450 activity in vivo. Clin. Pharmacol. Ther. 2004;75:89\u2013100. doi: 10.1016/j.clpt.2003.09.013.", "ArticleIdList": ["10.1016/j.clpt.2003.09.013", "14749695"]}, {"Citation": "Hellum B.H., Hu Z., Nilsen O.G. The induction of CYP1A2, CYP2D6 and CYP3A4 by six trade herbal products in cultured primary human hepatocytes. Basic Clin. Pharmacol. Toxicol. 2007;100:23\u201330. doi: 10.1111/j.1742-7843.2007.00011.x.", "ArticleIdList": ["10.1111/j.1742-7843.2007.00011.x", "17214607"]}, {"Citation": "Modarai M., Silva E., Suter A., Heinrich M., Kortenkamp A. Safety of Herbal Medicinal Products: Echinacea and Selected Alkylamides Do Not Induce CYP3A4 mRNA Expression. Evid.-Based Complement. Alternat. Med. 2011;2011:213021. doi: 10.1093/ecam/nep174.", "ArticleIdList": ["10.1093/ecam/nep174", "PMC3095427", "19906827"]}, {"Citation": "Molt\u00f3 J., Valle M., Miranda C., Cede\u00f1o S., Negredo E., Clotet B. Herb-drug interaction between Echinacea purpurea and etravirine in HIV-infected patients. Antimicrob. Agents Chemother. 2012;56:5328\u20135331. doi: 10.1128/AAC.01205-12.", "ArticleIdList": ["10.1128/AAC.01205-12", "PMC3457385", "22869560"]}, {"Citation": "Molt\u00f3 J., Valle M., Miranda C., Cede\u00f1o S., Negredo E., Barbanoj M.J., Clotet B. Herb-drug interaction between Echinacea purpurea and darunavir-ritonavir in HIV-infected patients. Antimicrob. Agents Chemother. 2011;55:326\u2013330. doi: 10.1128/AAC.01082-10.", "ArticleIdList": ["10.1128/AAC.01082-10", "PMC3019656", "21078942"]}, {"Citation": "European Union Herbal Monograph on Echinacea purpurea (L.) Moench, Radix. Committee on Herbal Medicinal Products (HMPC), European Medicines Agency; Amstersam, The Netherlands: 2017."}, {"Citation": "Bayles B., Usatine R. Evening primrose oil. Am. Fam. Physician. 2009;80:1405\u20131408.", "ArticleIdList": ["20000302"]}, {"Citation": "Bamford J.T., Ray S., Musekiwa A., van Gool C., Humphreys R., Ernst E. Oral evening primrose oil and borage oil for eczema. Cochrane Database Syst. Rev. 2013;2013:Cd004416. doi: 10.1002/14651858.CD004416.pub2.", "ArticleIdList": ["10.1002/14651858.CD004416.pub2", "PMC8105655", "23633319"]}, {"Citation": "Holman C.P., Bell A.F. A trial of evening primrose oil in the treatment of chronic schizophrenia. J. Orthomol. Psychiatry. 1983;12:302\u2013304."}, {"Citation": "Abo-Gresha N.M., Abel-Aziz E.Z., Greish S.M. Evening primrose oil ameliorates platelet aggregation and improves cardiac recovery in myocardial-infarct hypercholesterolemic rats. Int. J. Physiol. Pathophysiol. Pharmacol. 2014;6:23\u201336.", "ArticleIdList": ["PMC3961099", "24665356"]}, {"Citation": "Riaz A., Khan R.A., Ahmed S.P. Assessment of anticoagulant effect of evening primrose oil. Pak. J. Pharm. Sci. 2009;22:355\u2013359.", "ArticleIdList": ["19783511"]}, {"Citation": "Tomic-Smiljanic M., Vasiljevic D., Lucic-Tomic A., Andjelkovic N., Jakovljevic V., Bolovich S., Veselinovic M. Influence of different supplementation on platelet aggregation in patients with rheumatoid arthritis. Clin. Rheumatol. 2019;38:2443\u20132450. doi: 10.1007/s10067-019-04569-3.", "ArticleIdList": ["10.1007/s10067-019-04569-3", "31076942"]}, {"Citation": "Wang X., Jiang A., Batra V. Severe Thrombocytopenia Associated With Black Seed Oil and Evening Primrose Oil. Cureus. 2020;12:e8390. doi: 10.7759/cureus.8390.", "ArticleIdList": ["10.7759/cureus.8390", "PMC7331904", "32637272"]}, {"Citation": "Varshney R., Budoff M.J. Garlic and Heart Disease. J. Nutr. 2016;146:416s\u2013421s. doi: 10.3945/jn.114.202333.", "ArticleIdList": ["10.3945/jn.114.202333", "26764327"]}, {"Citation": "European Union Herbal Monograph on Allium sativum L., Bulbus. Committee on Herbal Medicinal Products (HMPC), European Medicines Agency; Amstersam, The Netherlands: 2017."}, {"Citation": "European Pharmacopoeia. 10th ed. German edition published by Bundesinstitut f\u00fcr Arzneimittel und Medizinprodukte, Bonn & Deutscher Apothekerverlag; Stuttgart, Germany: 2020."}, {"Citation": "Harris J.C., Cottrell S.L., Plummer S., Lloyd D. Antimicrobial properties of Allium sativum (garlic) Appl. Microbiol. Biotechnol. 2001;57:282\u2013286. doi: 10.1007/s002530100722.", "ArticleIdList": ["10.1007/s002530100722", "11759674"]}, {"Citation": "Block E. The chemistry of garlic and onions. Sci. Am. 1985;252:114\u2013119. doi: 10.1038/scientificamerican0385-114.", "ArticleIdList": ["10.1038/scientificamerican0385-114", "3975593"]}, {"Citation": "Satyal P., Craft J.D., Dosoky N.S., Setzer W.N. The Chemical Compositions of the Volatile Oils of Garlic (Allium sativum) and Wild Garlic (Allium vineale) Foods. 2017;6:63. doi: 10.3390/foods6080063.", "ArticleIdList": ["10.3390/foods6080063", "PMC5575638", "28783070"]}, {"Citation": "Lawson L.D., Gardner C.D. Composition, stability, and bioavailability of garlic products used in a clinical trial. J. Agric. Food Chem. 2005;53:6254\u20136261. doi: 10.1021/jf050536+.", "ArticleIdList": ["10.1021/jf050536+", "PMC2584604", "16076102"]}, {"Citation": "Amagase H. Clarifying the real bioactive constituents of garlic. J. Nutr. 2006;136:716s\u2013725s. doi: 10.1093/jn/136.3.716S.", "ArticleIdList": ["10.1093/jn/136.3.716S", "16484550"]}, {"Citation": "Rose K.D., Croissant P.D., Parliament C.F., Levin M.B. Spontaneous spinal epidural hematoma with associated platelet dysfunction from excessive garlic ingestion: A case report. Neurosurgery. 1990;26:880\u2013882. doi: 10.1227/00006123-199005000-00026.", "ArticleIdList": ["10.1227/00006123-199005000-00026", "2352608"]}, {"Citation": "Burnham B.E. Garlic as a possible risk for postoperative bleeding. Plast. Reconstr. Surg. 1995;95:213. doi: 10.1097/00006534-199501000-00060.", "ArticleIdList": ["10.1097/00006534-199501000-00060", "7809259"]}, {"Citation": "Macan H., Uykimpang R., Alconcel M., Takasu J., Razon R., Amagase H., Niihara Y. Aged garlic extract may be safe for patients on warfarin therapy. J. Nutr. 2006;136:793s\u2013795s. doi: 10.1093/jn/136.3.793S.", "ArticleIdList": ["10.1093/jn/136.3.793S", "16484565"]}, {"Citation": "Tebonin Spezial 80 mg [Prescription Information] Dr. Willmar Schwabe GmbH & Co. KG; Karlsruhe, Germany: 2019."}, {"Citation": "Liu Z.H., Zeng S. Cytotoxicity of ginkgolic acid in HepG2 cells and primary rat hepatocytes. Toxicol. Lett. 2009;187:131\u2013136. doi: 10.1016/j.toxlet.2009.02.012.", "ArticleIdList": ["10.1016/j.toxlet.2009.02.012", "19429255"]}, {"Citation": "Robertson S.M., Davey R.T., Voell J., Formentini E., Alfaro R.M., Penzak S.R. Effect of Ginkgo biloba extract on lopinavir, midazolam and fexofenadine pharmacokinetics in healthy subjects. Curr. Med. Res. Opin. 2008;24:591\u2013599. doi: 10.1185/030079908X260871.", "ArticleIdList": ["10.1185/030079908X260871", "18205997"]}, {"Citation": "Gurley B.J., Gardner S.F., Hubbard M.A., Williams D.K., Gentry W.B., Cui Y., Ang C.Y. Cytochrome P450 phenotypic ratios for predicting herb-drug interactions in humans. Clin. Pharmacol. Ther. 2002;72:276\u2013287. doi: 10.1067/mcp.2002.126913.", "ArticleIdList": ["10.1067/mcp.2002.126913", "12235448"]}, {"Citation": "Zadoyan G., Rokitta D., Klement S., Dienel A., Hoerr R., Gramatt\u00e9 T., Fuhr U. Effect of Ginkgo biloba special extract EGb 761\u00ae on human cytochrome P450 activity: A cocktail interaction study in healthy volunteers. Eur. J. Clin. Pharmacol. 2012;68:553\u2013560. doi: 10.1007/s00228-011-1174-5.", "ArticleIdList": ["10.1007/s00228-011-1174-5", "PMC3332346", "22189672"]}, {"Citation": "Awortwe C., Bruckmueller H., Cascorbi I. Interaction of herbal products with prescribed medications: A systematic review and meta-analysis. Pharmacol. Res. 2019;141:397\u2013408. doi: 10.1016/j.phrs.2019.01.028.", "ArticleIdList": ["10.1016/j.phrs.2019.01.028", "30660822"]}, {"Citation": "Bent S., Goldberg H., Padula A., Avins A.L. Spontaneous bleeding associated with ginkgo biloba: A case report and systematic review of the literature: A case report and systematic review of the literature. J. Gen. Intern. Med. 2005;20:657\u2013661. doi: 10.1007/s11606-005-0114-4.", "ArticleIdList": ["10.1007/s11606-005-0114-4", "PMC1490168", "16050865"]}, {"Citation": "Yagmur E., Piatkowski A., Gr\u00f6ger A., Pallua N., Gressner A.M., Kiefer P. Bleeding complication under Gingko biloba medication. Am. J. Hematol. 2005;79:343\u2013344. doi: 10.1002/ajh.20346.", "ArticleIdList": ["10.1002/ajh.20346", "16044448"]}, {"Citation": "Koch E. Inhibition of platelet activating factor (PAF)-induced aggregation of human thrombocytes by ginkgolides: Considerations on possible bleeding complications after oral intake of Ginkgo biloba extracts. Phytomedicine. 2005;12:10\u201316. doi: 10.1016/j.phymed.2004.02.002.", "ArticleIdList": ["10.1016/j.phymed.2004.02.002", "15693702"]}, {"Citation": "Chen T.R., Wei L.H., Guan X.Q., Huang C., Liu Z.Y., Wang F.J., Hou J., Jin Q., Liu Y.F., Wen P.H., et al. Biflavones from Ginkgo biloba as inhibitors of human thrombin. Bioorg. Chem. 2019;92:103199. doi: 10.1016/j.bioorg.2019.103199.", "ArticleIdList": ["10.1016/j.bioorg.2019.103199", "31446241"]}, {"Citation": "Bal Dit Sollier C., Caplain H., Drouet L. No alteration in platelet function or coagulation induced by EGb761 in a controlled study. Clin. Lab. Haematol. 2003;25:251\u2013253. doi: 10.1046/j.1365-2257.2003.00527.x.", "ArticleIdList": ["10.1046/j.1365-2257.2003.00527.x", "12890165"]}, {"Citation": "Savovi\u0107 J., Wider B., Ernst E. Effects of Ginkgo biloba on Blood Coagulation Parameters. Evid.-Based Integr. Med. 2005;2:167\u2013176. doi: 10.2165/01197065-200502030-00007.", "ArticleIdList": ["10.2165/01197065-200502030-00007"]}, {"Citation": "Gardner C.D., Zehnder J.L., Rigby A.J., Nicholus J.R., Farquhar J.W. Effect of Ginkgo biloba (EGb 761) and aspirin on platelet aggregation and platelet function analysis among older adults at risk of cardiovascular disease: A randomized clinical trial. Blood Coagul. Fibrinolysis. 2007;18:787\u2013793. doi: 10.1097/MBC.0b013e3282f102b1.", "ArticleIdList": ["10.1097/MBC.0b013e3282f102b1", "17982321"]}, {"Citation": "Stoddard G.J., Archer M., Shane-McWhorter L., Bray B.E., Redd D.F., Proulx J., Zeng-Treitler Q. Ginkgo and Warfarin Interaction in a Large Veterans Administration Population. AMIA Annu. Symp. Proc. 2015;2015:1174\u20131183.", "ArticleIdList": ["PMC4765589", "26958257"]}, {"Citation": "Todorova V., Ivanov K., Delattre C., Nalbantova V., Karcheva-Bahchevanska D., Ivanova S. Plant Adaptogens-History and Future Perspectives. Nutrients. 2021;13:2861. doi: 10.3390/nu13082861.", "ArticleIdList": ["10.3390/nu13082861", "PMC8398443", "34445021"]}, {"Citation": "Malati C.Y., Robertson S.M., Hunt J.D., Chairez C., Alfaro R.M., Kovacs J.A., Penzak S.R. Influence of Panax ginseng on cytochrome P450 (CYP)3A and P-glycoprotein (P-gp) activity in healthy participants. J. Clin. Pharmacol. 2012;52:932\u2013939. doi: 10.1177/0091270011407194.", "ArticleIdList": ["10.1177/0091270011407194", "PMC3523324", "21646440"]}, {"Citation": "Kim M.G., Kim Y., Jeon J.Y., Kim D.S. Effect of fermented red ginseng on cytochrome P450 and P-glycoprotein activity in healthy subjects, as evaluated using the cocktail approach. Br. J. Clin. Pharmacol. 2016;82:1580\u20131590. doi: 10.1111/bcp.13080.", "ArticleIdList": ["10.1111/bcp.13080", "PMC5099554", "27495955"]}, {"Citation": "Bilgi N., Bell K., Ananthakrishnan A.N., Atallah E. Imatinib and Panax ginseng: A potential interaction resulting in liver toxicity. Ann. Pharmacother. 2010;44:926\u2013928. doi: 10.1345/aph.1M715.", "ArticleIdList": ["10.1345/aph.1M715", "20332334"]}, {"Citation": "Seong S.J., Kang W.Y., Heo J.K., Jo J., Choi W.G., Liu K.H., Lee S., Choi M.K., Han Y.H., Lee H.S., et al. A Comprehensive In Vivo and In Vitro Assessment of the Drug Interaction Potential of Red Ginseng. Clin. Ther. 2018;40:1322\u20131337. doi: 10.1016/j.clinthera.2018.06.017.", "ArticleIdList": ["10.1016/j.clinthera.2018.06.017", "30078466"]}, {"Citation": "Hao M., Ba Q., Yin J., Li J., Zhao Y., Wang H. Deglycosylated ginsenosides are more potent inducers of CYP1A1, CYP1A2 and CYP3A4 expression in HepG2 cells than glycosylated ginsenosides. Drug Metab. Pharmacokinet. 2011;26:201\u2013205. doi: 10.2133/dmpk.DMPK-10-NT-056.", "ArticleIdList": ["10.2133/dmpk.DMPK-10-NT-056", "21178302"]}, {"Citation": "Laube R., Liu K. An unwanted complement: Rare case of potential liver injury induced by an interaction between ginseng and atorvastatin. Br. J. Clin. Pharmacol. 2019;85:1612\u20131613. doi: 10.1111/bcp.13927.", "ArticleIdList": ["10.1111/bcp.13927", "PMC6595312", "30980549"]}, {"Citation": "Lee Y.H., Lee B.K., Choi Y.J., Yoon I.K., Chang B.C., Gwak H.S. Interaction between warfarin and Korean red ginseng in patients with cardiac valve replacement. Int. J. Cardiol. 2010;145:275\u2013276. doi: 10.1016/j.ijcard.2009.09.553.", "ArticleIdList": ["10.1016/j.ijcard.2009.09.553", "19913311"]}, {"Citation": "Wang W., Yang L., Song L., Guo M., Li C., Yang B., Wang M., Kou N., Gao J., Qu H., et al. Combination of Panax notoginseng saponins and aspirin potentiates platelet inhibition with alleviated gastric injury via modulating arachidonic acid metabolism. Biomed. Pharmacother. 2021;134:111165. doi: 10.1016/j.biopha.2020.111165.", "ArticleIdList": ["10.1016/j.biopha.2020.111165", "33370633"]}, {"Citation": "Lau A.J., Toh D.F., Chua T.K., Pang Y.K., Woo S.O., Koh H.L. Antiplatelet and anticoagulant effects of Panax notoginseng: Comparison of raw and steamed Panax notoginseng with Panax ginseng and Panax quinquefolium. J. Ethnopharmacol. 2009;125:380\u2013386. doi: 10.1016/j.jep.2009.07.038.", "ArticleIdList": ["10.1016/j.jep.2009.07.038", "19665534"]}, {"Citation": "Kwon H.W. Inhibitory Effect of 20(S)-Ginsenoside Rg3 on Human Platelet Aggregation and Intracellular Ca(2+) Levels via Cyclic Adenosine Monophosphate Dependent Manner. Prev. Nutr. Food Sci. 2018;23:317\u2013325. doi: 10.3746/pnf.2018.23.4.317.", "ArticleIdList": ["10.3746/pnf.2018.23.4.317", "PMC6342537", "30675461"]}, {"Citation": "Tian Z., Pang H., Du S., Lu Y., Zhang L., Wu H., Guo S., Wang M., Zhang Q. Effect of Panax notoginseng saponins on the pharmacokinetics of aspirin in rats. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2017;1040:136\u2013143. doi: 10.1016/j.jchromb.2016.12.007.", "ArticleIdList": ["10.1016/j.jchromb.2016.12.007", "27978468"]}, {"Citation": "Tian Z., Pang H., Zhang Q., Du S., Lu Y., Zhang L., Bai J., Li P., Li D., Zhao M., et al. Effect of aspirin on the pharmacokinetics and absorption of panax notoginseng saponins. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2018;1074-1075:25\u201333. doi: 10.1016/j.jchromb.2017.12.033.", "ArticleIdList": ["10.1016/j.jchromb.2017.12.033", "29329092"]}, {"Citation": "Fung F.Y., Wong W.H., Ang S.K., Koh H.L., Kun M.C., Lee L.H., Li X., Ng H.J., Tan C.W., Zhao Y., et al. A randomized, double-blind, placebo- controlled study on the anti-haemostatic effects of Curcuma longa, Angelica sinensis and Panax ginseng. Phytomedicine. 2017;32:88\u201396. doi: 10.1016/j.phymed.2017.04.004.", "ArticleIdList": ["10.1016/j.phymed.2017.04.004", "28732813"]}, {"Citation": "Yuan C.S., Wei G., Dey L., Karrison T., Nahlik L., Maleckar S., Kasza K., Ang-Lee M., Moss J. Brief communication: American ginseng reduces warfarin\u2019s effect in healthy patients: A randomized, controlled Trial. Ann. Intern. Med. 2004;141:23\u201327. doi: 10.7326/0003-4819-141-1-200407060-00011.", "ArticleIdList": ["10.7326/0003-4819-141-1-200407060-00011", "15238367"]}, {"Citation": "Chen W., Balan P., Popovich D.G. Review of Ginseng Anti-Diabetic Studies. Molecules. 2019;24:4501. doi: 10.3390/molecules24244501.", "ArticleIdList": ["10.3390/molecules24244501", "PMC6943541", "31835292"]}, {"Citation": "Choi M.K., Song I.S. Interactions of ginseng with therapeutic drugs. Arch. Pharm. Res. 2019;42:862\u2013878. doi: 10.1007/s12272-019-01184-3.", "ArticleIdList": ["10.1007/s12272-019-01184-3", "31493264"]}, {"Citation": "Khan N., Mukhtar H. Tea Polyphenols in Promotion of Human Health. Nutrients. 2018;11:39. doi: 10.3390/nu11010039.", "ArticleIdList": ["10.3390/nu11010039", "PMC6356332", "30585192"]}, {"Citation": "Dey M., Cutolo M., Nikiphorou E. Beverages in Rheumatoid Arthritis: What to Prefer or to Avoid. Nutrients. 2020;12:3155. doi: 10.3390/nu12103155.", "ArticleIdList": ["10.3390/nu12103155", "PMC7602656", "33076469"]}, {"Citation": "EFSA Panel on Food Additives and Nutrient Sources added to Food (ANS) Younes M., Aggett P., Aguilar F., Crebelli R., Dusemund B., Filipi\u010d M., Frutos M.J., Galtier P., Gott D., et al. Scientific opinion on the safety of green tea catechins. EFSA J. 2018;16:e05239. doi: 10.2903/j.efsa.2018.5239.", "ArticleIdList": ["10.2903/j.efsa.2018.5239", "PMC7009618", "32625874"]}, {"Citation": "Dostal A.M., Samavat H., Bedell S., Torkelson C., Wang R., Swenson K., Le C., Wu A.H., Ursin G., Yuan J.M., et al. The safety of green tea extract supplementation in postmenopausal women at risk for breast cancer: Results of the Minnesota Green Tea Trial. Food Chem. Toxicol. 2015;83:26\u201335. doi: 10.1016/j.fct.2015.05.019.", "ArticleIdList": ["10.1016/j.fct.2015.05.019", "PMC4540665", "26051348"]}, {"Citation": "Yu Z., Samavat H., Dostal A.M., Wang R., Torkelson C.J., Yang C.S., Butler L.M., Kensler T.W., Wu A.H., Kurzer M.S., et al. Effect of Green Tea Supplements on Liver Enzyme Elevation: Results from a Randomized Intervention Study in the United States. Cancer Prev. Res. (Phila) 2017;10:571\u2013579. doi: 10.1158/1940-6207.CAPR-17-0160.", "ArticleIdList": ["10.1158/1940-6207.CAPR-17-0160", "PMC9257888", "28765194"]}, {"Citation": "Salminen W.F., Yang X., Shi Q., Greenhaw J., Davis K., Ali A.A. Green tea extract can potentiate acetaminophen-induced hepatotoxicity in mice. Food Chem. Toxicol. 2012;50:1439\u20131446. doi: 10.1016/j.fct.2012.01.027.", "ArticleIdList": ["10.1016/j.fct.2012.01.027", "22306919"]}, {"Citation": "Lu Y., Sun J., Petrova K., Yang X., Greenhaw J., Salminen W.F., Beger R.D., Schnackenberg L.K. Metabolomics evaluation of the effects of green tea extract on acetaminophen-induced hepatotoxicity in mice. Food Chem. Toxicol. 2013;62:707\u2013721. doi: 10.1016/j.fct.2013.09.025.", "ArticleIdList": ["10.1016/j.fct.2013.09.025", "24080264"]}, {"Citation": "Taylor J.R., Wilt V.M. Probable antagonism of warfarin by green tea. Ann. Pharmacother. 1999;33:426\u2013428. doi: 10.1345/aph.18238.", "ArticleIdList": ["10.1345/aph.18238", "10332534"]}, {"Citation": "Greenblatt D.J., von Moltke L.L., Perloff E.S., Luo Y., Harmatz J.S., Zinny M.A. Interaction of flurbiprofen with cranberry juice, grape juice, tea, and fluconazole: In vitro and clinical studies. Clin. Pharmacol. Ther. 2006;79:125\u2013133. doi: 10.1016/j.clpt.2005.09.014.", "ArticleIdList": ["10.1016/j.clpt.2005.09.014", "16413247"]}, {"Citation": "Misaka S., Kawabe K., Onoue S., Werba J.P., Giroli M., Tamaki S., Kan T., Kimura J., Watanabe H., Yamada S. Effects of green tea catechins on cytochrome P450 2B6, 2C8, 2C19, 2D6 and 3A activities in human liver and intestinal microsomes. Drug Metab. Pharmacokinet. 2013;28:244\u2013249. doi: 10.2133/dmpk.DMPK-12-RG-101.", "ArticleIdList": ["10.2133/dmpk.DMPK-12-RG-101", "23268924"]}, {"Citation": "Yao H.T., Hsu Y.R., Li M.L. Beverage-Drug Interaction: Effects of Green Tea Beverage Consumption on Atorvastatin Metabolism and Membrane Transporters in the Small Intestine and Liver of Rats. Membranes. 2020;10:233. doi: 10.3390/membranes10090233.", "ArticleIdList": ["10.3390/membranes10090233", "PMC7559440", "32937767"]}, {"Citation": "Donovan J.L., Chavin K.D., Devane C.L., Taylor R.M., Wang J.S., Ruan Y., Markowitz J.S. Green tea (Camellia sinensis) extract does not alter cytochrome p450 3A4 or 2D6 activity in healthy volunteers. Drug Metab. Dispos. 2004;32:906\u2013908. doi: 10.1124/dmd.104.000083.", "ArticleIdList": ["10.1124/dmd.104.000083", "15319329"]}, {"Citation": "Chow H.H., Hakim I.A., Vining D.R., Crowell J.A., Cordova C.A., Chew W.M., Xu M.J., Hsu C.H., Ranger-Moore J., Alberts D.S. Effects of repeated green tea catechin administration on human cytochrome P450 activity. Cancer Epidemiol. Biomark. Prev. 2006;15:2473\u20132476. doi: 10.1158/1055-9965.EPI-06-0365.", "ArticleIdList": ["10.1158/1055-9965.EPI-06-0365", "17164372"]}, {"Citation": "Vischini G., Niscola P., Stefoni A., Farneti F. Increased plasma levels of tacrolimus after ingestion of green tea. Am. J. Kidney Dis. 2011;58:329. doi: 10.1053/j.ajkd.2011.05.013.", "ArticleIdList": ["10.1053/j.ajkd.2011.05.013", "21787983"]}, {"Citation": "Jodoin J., Demeule M., Beliveau R. Inhibition of the multidrug resistance P-glycoprotein activity by green tea polyphenols. Biochim. Biophys. Acta. 2002;1542:149\u2013159. doi: 10.1016/S0167-4889(01)00175-6.", "ArticleIdList": ["10.1016/S0167-4889(01)00175-6", "11853888"]}, {"Citation": "Knop J., Misaka S., Singer K., Hoier E., M\u00fcller F., Glaeser H., K\u00f6nig J., Fromm M.F. Inhibitory Effects of Green Tea and (-)-Epigallocatechin Gallate on Transport by OATP1B1, OATP1B3, OCT1, OCT2, MATE1, MATE2-K and P-Glycoprotein. PLoS ONE. 2015;10:e0139370. doi: 10.1371/journal.pone.0139370.", "ArticleIdList": ["10.1371/journal.pone.0139370", "PMC4591125", "26426900"]}, {"Citation": "Kim T.E., Shin K.H., Park J.E., Kim M.G., Yun Y.M., Choi D.H., Kwon K.J., Lee J. Effect of green tea catechins on the pharmacokinetics of digoxin in humans. Drug Des. Devel. Ther. 2018;12:2139\u20132147. doi: 10.2147/DDDT.S148257.", "ArticleIdList": ["10.2147/DDDT.S148257", "PMC6044363", "30022812"]}, {"Citation": "Alemdaroglu N.C., Wolffram S., Boissel J.P., Closs E., Spahn-Langguth H., Langguth P. Inhibition of folic acid uptake by catechins and tea extracts in Caco-2 cells. Planta Med. 2007;73:27\u201332. doi: 10.1055/s-2006-951745.", "ArticleIdList": ["10.1055/s-2006-951745", "17117344"]}, {"Citation": "Lemos C., Peters G.J., Jansen G., Martel F., Calhau C. Modulation of folate uptake in cultured human colon adenocarcinoma Caco-2 cells by dietary compounds. Eur. J. Nutr. 2007;46:329\u2013336. doi: 10.1007/s00394-007-0670-y.", "ArticleIdList": ["10.1007/s00394-007-0670-y", "17712586"]}, {"Citation": "Kissei M., Itoh T., Narawa T. Effect of epigallocatechin gallate on drug transport mediated by the proton-coupled folate transporter. Drug Metab. Pharmacokinet. 2014;29:367\u2013372. doi: 10.2133/dmpk.DMPK-14-RG-015.", "ArticleIdList": ["10.2133/dmpk.DMPK-14-RG-015", "24695276"]}, {"Citation": "Navarro-Per\u00e1n E., Cabezas-Herrera J., Garc\u00eda-C\u00e1novas F., Durrant M.C., Thorneley R.N., Rodr\u00edguez-L\u00f3pez J.N. The antifolate activity of tea catechins. Cancer Res. 2005;65:2059\u20132064. doi: 10.1158/0008-5472.CAN-04-3469.", "ArticleIdList": ["10.1158/0008-5472.CAN-04-3469", "15781612"]}, {"Citation": "Alemdaroglu N.C., Dietz U., Wolffram S., Spahn-Langguth H., Langguth P. Influence of green and black tea on folic acid pharmacokinetics in healthy volunteers: Potential risk of diminished folic acid bioavailability. Biopharm. Drug Dispos. 2008;29:335\u2013348. doi: 10.1002/bdd.617.", "ArticleIdList": ["10.1002/bdd.617", "18551467"]}, {"Citation": "Augustin K., Frank J., Augustin S., Langguth P., Ohrvik V., Witthoft C.M., Rimbach G., Wolffram S. Greeen tea extracts lower serum folates in rats at very high dietary concentrations only and do not affect plasma folates in a human pilot study. J. Physiol. Pharmacol. 2009;60:103\u2013108.", "ArticleIdList": ["19826188"]}, {"Citation": "Abe O., Ono T., Sato H., M\u00fcller F., Ogata H., Miura I., Shikama Y., Yabe H., Onoue S., Fromm M.F., et al. Role of (-)-epigallocatechin gallate in the pharmacokinetic interaction between nadolol and green tea in healthy volunteers. Eur. J. Clin. Pharmacol. 2018;74:775\u2013783. doi: 10.1007/s00228-018-2436-2.", "ArticleIdList": ["10.1007/s00228-018-2436-2", "29480324"]}, {"Citation": "Misaka S., Yatabe J., M\u00fcller F., Takano K., Kawabe K., Glaeser H., Yatabe M.S., Onoue S., Werba J.P., Watanabe H., et al. Green tea ingestion greatly reduces plasma concentrations of nadolol in healthy subjects. Clin. Pharmacol. Ther. 2014;95:432\u2013438. doi: 10.1038/clpt.2013.241.", "ArticleIdList": ["10.1038/clpt.2013.241", "24739447"]}, {"Citation": "Misaka S., Abe O., Ono T., Ono Y., Ogata H., Miura I., Shikama Y., Fromm M.F., Yabe H., Shimomura K. Effects of single green tea ingestion on pharmacokinetics of nadolol in healthy volunteers. Br. J. Clin. Pharmacol. 2020;86:2314\u20132318. doi: 10.1111/bcp.14315.", "ArticleIdList": ["10.1111/bcp.14315", "PMC7576630", "32320490"]}, {"Citation": "Roth M., Timmermann B.N., Hagenbuch B. Interactions of green tea catechins with organic anion-transporting polypeptides. Drug Metab. Dispos. 2011;39:920\u2013926. doi: 10.1124/dmd.110.036640.", "ArticleIdList": ["10.1124/dmd.110.036640", "PMC3082372", "21278283"]}, {"Citation": "Kalliokoski A., Niemi M. Impact of OATP transporters on pharmacokinetics. Br. J. Pharmacol. 2009;158:693\u2013705. doi: 10.1111/j.1476-5381.2009.00430.x.", "ArticleIdList": ["10.1111/j.1476-5381.2009.00430.x", "PMC2765590", "19785645"]}, {"Citation": "Malaviya A.N. Methotrexate intolerance in the treatment of rheumatoid arthritis (RA): Effect of adding caffeine to the management regimen. Clin. Rheumatol. 2017;36:279\u2013285. doi: 10.1007/s10067-016-3398-3.", "ArticleIdList": ["10.1007/s10067-016-3398-3", "27596742"]}, {"Citation": "Chin K.Y. The spice for joint inflammation: Anti-inflammatory role of curcumin in treating osteoarthritis. Drug Des. Devel. Ther. 2016;10:3029\u20133042. doi: 10.2147/DDDT.S117432.", "ArticleIdList": ["10.2147/DDDT.S117432", "PMC5036591", "27703331"]}, {"Citation": "Mazieiro R., Frizon R.R., Barbalho S.M., Goulart R.A. Is Curcumin a Possibility to Treat Inflammatory Bowel Diseases? J. Med. Food. 2018;21:1077\u20131085. doi: 10.1089/jmf.2017.0146.", "ArticleIdList": ["10.1089/jmf.2017.0146", "29957091"]}, {"Citation": "Coelho M.R., Romi M.D., Ferreira D., Zaltman C., Soares-Mota M. The Use of Curcumin as a Complementary Therapy in Ulcerative Colitis: A Systematic Review of Randomized Controlled Clinical Trials. Nutrients. 2020;12:2296. doi: 10.3390/nu12082296.", "ArticleIdList": ["10.3390/nu12082296", "PMC7468803", "32751776"]}, {"Citation": "Daily J.W., Yang M., Park S. Efficacy of Turmeric Extracts and Curcumin for Alleviating the Symptoms of Joint Arthritis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. J. Med. Food. 2016;19:717\u2013729. doi: 10.1089/jmf.2016.3705.", "ArticleIdList": ["10.1089/jmf.2016.3705", "PMC5003001", "27533649"]}, {"Citation": "Ipar V.S., Dsouza A., Devarajan P.V. Enhancing Curcumin Oral Bioavailability Through Nanoformulations. Eur. J. Drug Metab. Pharmacokinet. 2019;44:459\u2013480. doi: 10.1007/s13318-019-00545-z.", "ArticleIdList": ["10.1007/s13318-019-00545-z", "30771095"]}, {"Citation": "Dei Cas M., Ghidoni R. Dietary Curcumin: Correlation between Bioavailability and Health Potential. Nutrients. 2019;11:2147. doi: 10.3390/nu11092147.", "ArticleIdList": ["10.3390/nu11092147", "PMC6770259", "31500361"]}, {"Citation": "Lopresti A.L. The Problem of Curcumin and Its Bioavailability: Could Its Gastrointestinal Influence Contribute to Its Overall Health-Enhancing Effects? Adv. Nutr. 2018;9:41\u201350. doi: 10.1093/advances/nmx011.", "ArticleIdList": ["10.1093/advances/nmx011", "PMC6333932", "29438458"]}, {"Citation": "Volak L.P., Ghirmai S., Cashman J.R., Court M.H. Curcuminoids inhibit multiple human cytochromes P450, UDP-glucuronosyltransferase, and sulfotransferase enzymes, whereas piperine is a relatively selective CYP3A4 inhibitor. Drug Metab. Dispos. 2008;36:1594\u20131605. doi: 10.1124/dmd.108.020552.", "ArticleIdList": ["10.1124/dmd.108.020552", "PMC2574793", "18480186"]}, {"Citation": "Al-Jenoobi F.I., Al-Thukair A.A., Alam M.A., Abbas F.A., Al-Mohizea A.M., Alkharfy K.M., Al-Suwayeh S.A. Effect of Curcuma longa on CYP2D6- and CYP3A4-mediated metabolism of dextromethorphan in human liver microsomes and healthy human subjects. Eur. J. Drug Metab. Pharmacokinet. 2015;40:61\u201366. doi: 10.1007/s13318-014-0180-2.", "ArticleIdList": ["10.1007/s13318-014-0180-2", "24510399"]}, {"Citation": "Rusdiana T., Mardhiani Y.D., Putriana N.A., Gozali D., Nagano D., Araki T., Yamamoto K. The influence of Javanese turmeric (Curcuma xanthorrhiza) on the pharmacokinetics of warfarin in rats with single and multiple-dose studies. Pharm Biol. 2021;59:639\u2013646. doi: 10.1080/13880209.2021.1928716.", "ArticleIdList": ["10.1080/13880209.2021.1928716", "PMC8172219", "34062109"]}, {"Citation": "Salleh N.A., Ismail S., Ab Halim M.R. Effects of Curcuma xanthorrhiza Extracts and Their Constituents on Phase II Drug-metabolizing Enzymes Activity. Pharmacogn. Res. 2016;8:309\u2013315. doi: 10.4103/0974-8490.188873.", "ArticleIdList": ["10.4103/0974-8490.188873", "PMC5004525", "27695274"]}, {"Citation": "Krivoy N., Pavlotzky E., Chrubasik S., Eisenberg E., Brook G. Effect of salicis cortex extract on human platelet aggregation. Planta Med. 2001;67:209\u2013212. doi: 10.1055/s-2001-12000.", "ArticleIdList": ["10.1055/s-2001-12000", "11345689"]}, {"Citation": "Catella-Lawson F., Reilly M.P., Kapoor S.C., Cucchiara A.J., DeMarco S., Tournier B., Vyas S.N., FitzGerald G.A. Cyclooxygenase inhibitors and the antiplatelet effects of aspirin. N. Engl. J. Med. 2001;345:1809\u20131817. doi: 10.1056/NEJMoa003199.", "ArticleIdList": ["10.1056/NEJMoa003199", "11752357"]}, {"Citation": "Vlachojannis J., Magora F., Chrubasik S. Willow species and aspirin: Different mechanism of actions. Phytother. Res. 2011;25:1102\u20131104. doi: 10.1002/ptr.3386.", "ArticleIdList": ["10.1002/ptr.3386", "21226125"]}, {"Citation": "Gagnier J.J., Oltean H., van Tulder M.W., Berman B.M., Bombardier C., Robbins C.B. Herbal Medicine for Low Back Pain: A Cochrane Review. Spine. 2016;41:116\u2013133. doi: 10.1097/BRS.0000000000001310.", "ArticleIdList": ["10.1097/BRS.0000000000001310", "26630428"]}, {"Citation": "Biegert C., Wagner I., L\u00fcdtke R., K\u00f6tter I., Lohm\u00fcller C., G\u00fcnaydin I., Taxis K., Heide L. Efficacy and safety of willow bark extract in the treatment of osteoarthritis and rheumatoid arthritis: Results of 2 randomized double-blind controlled trials. J. Rheumatol. 2004;31:2121\u20132130.", "ArticleIdList": ["15517622"]}, {"Citation": "Stewart C.F., Fleming R.A., Germain B.F., Seleznick M.J., Evans W.E. Aspirin alters methotrexate disposition in rheumatoid arthritis patients. Arthritis Rheum. 1991;34:1514\u20131520. doi: 10.1002/art.1780341207.", "ArticleIdList": ["10.1002/art.1780341207", "1747136"]}, {"Citation": "Tracy T.S., Krohn K., Jones D.R., Bradley J.D., Hall S.D., Brater D.C. The effects of a salicylate, ibuprofen, and naproxen on the disposition of methotrexate in patients with rheumatoid arthritis. Eur. J. Clin. Pharmacol. 1992;42:121\u2013125. doi: 10.1007/BF00278469.", "ArticleIdList": ["10.1007/BF00278469", "1618240"]}, {"Citation": "Gilbert B., Alves L.F. Synergy in plant medicines. Curr. Med. Chem. 2003;10:13\u201320. doi: 10.2174/0929867033368583.", "ArticleIdList": ["10.2174/0929867033368583", "12570718"]}, {"Citation": "Gertsch J. Botanical drugs, synergy, and network pharmacology: Forth and back to intelligent mixtures. Planta Med. 2011;77:1086\u20131098. doi: 10.1055/s-0030-1270904.", "ArticleIdList": ["10.1055/s-0030-1270904", "21412698"]}, {"Citation": "D\u2019Ascola A., Irrera N., Ettari R., Bitto A., Pallio G., Mannino F., Atteritano M., Campo G.M., Minutoli L., Arcoraci V., et al. Exploiting Curcumin Synergy With Natural Products Using Quantitative Analysis of Dose-Effect Relationships in an Experimental In Vitro Model of Osteoarthritis. Front. Pharmacol. 2019;10:1347. doi: 10.3389/fphar.2019.01347.", "ArticleIdList": ["10.3389/fphar.2019.01347", "PMC6868087", "31798452"]}, {"Citation": "Guideline on Declaration of Herbal Substances and Herbal Preparations in Herbal Medicinal Products/Traditional Herbal Medicinal Products. Committee on Herbal Medicinal Products (HMPC), European Medicines Agency; Amstersam, The Netherlands: 2010."}, {"Citation": "Ushijima K., Tsuruoka S., Tsuda H., Hasegawa G., Obi Y., Kaneda T., Takahashi M., Maekawa T., Sasaki T., Koshimizu T.A., et al. Cranberry juice suppressed the diclofenac metabolism by human liver microsomes, but not in healthy human subjects. Br. J. Clin. Pharmacol. 2009;68:194\u2013200. doi: 10.1111/j.1365-2125.2009.03436.x.", "ArticleIdList": ["10.1111/j.1365-2125.2009.03436.x", "PMC2767282", "19694738"]}, {"Citation": "Markowitz J.S., Zhu H.J. Limitations of in vitro assessments of the drug interaction potential of botanical supplements. Planta Med. 2012;78:1421\u20131427. doi: 10.1055/s-0032-1315025.", "ArticleIdList": ["10.1055/s-0032-1315025", "22814819"]}, {"Citation": "Rocha T., Amaral J.S., Oliveira M. Adulteration of Dietary Supplements by the Illegal Addition of Synthetic Drugs: A Review. Compr. Rev. Food Sci. Food Saf. 2016;15:43\u201362. doi: 10.1111/1541-4337.12173.", "ArticleIdList": ["10.1111/1541-4337.12173", "33371574"]}, {"Citation": "Tokem Y., Aytemur Z.A., Yildirim Y., Fadiloglu C. Investigation into the use of complementary and alternative medicine and affecting factors in Turkish asthmatic patients. J. Clin. Nurs. 2012;21:698\u2013707. doi: 10.1111/j.1365-2702.2011.03823.x.", "ArticleIdList": ["10.1111/j.1365-2702.2011.03823.x", "22040480"]}, {"Citation": "Young L.A., Faurot K.R., Gaylord S.A. Use of and communication about dietary supplements among hospitalized patients. J. Gen. Intern. Med. 2009;24:366\u2013369. doi: 10.1007/s11606-008-0890-8.", "ArticleIdList": ["10.1007/s11606-008-0890-8", "PMC2642560", "19096896"]}, {"Citation": "Hensrud D.D., Engle D.D., Scheitel S.M. Underreporting the use of dietary supplements and nonprescription medications among patients undergoing a periodic health examination. Mayo Clin. Proc. 1999;74:443\u2013447. doi: 10.1016/S0025-6196(11)65120-3.", "ArticleIdList": ["10.1016/S0025-6196(11)65120-3", "10319072"]}, {"Citation": "Jong M.C., van de Vijver L., Busch M., Fritsma J., Seldenrijk R. Integration of complementary and alternative medicine in primary care: What do patients want? Patient Educ. Couns. 2012;89:417\u2013422. doi: 10.1016/j.pec.2012.08.013.", "ArticleIdList": ["10.1016/j.pec.2012.08.013", "23031611"]}, {"Citation": "Agbabiaka T.B., Wider B., Watson L.K., Goodman C. Concurrent Use of Prescription Drugs and Herbal Medicinal Products in Older Adults: A Systematic Review. Drugs Aging. 2017;34:891\u2013905. doi: 10.1007/s40266-017-0501-7.", "ArticleIdList": ["10.1007/s40266-017-0501-7", "PMC5730633", "29196903"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "1", "Day": "12"}, {"Year": "2022", "Month": "2", "Day": "28"}, {"Year": "2022", "Month": "3", "Day": "9"}, {"Year": "2022", "Month": "3", "Day": "25", "Hour": "1", "Minute": "11"}, {"Year": "2022", "Month": "3", "Day": "26", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "3", "Day": "26", "Hour": "6", "Minute": "1"}, {"Year": "2022", "Month": "3", "Day": "12"}], "PublicationStatus": "epublish", "ArticleIdList": ["35329893", "PMC8951360", "10.3390/jcm11061567", "jcm11061567"]}}], "PubmedBookArticle": []}